Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
Operating Expenses | 9,230 | 9,829 | 8,503 | 7,706 | 5,677 |
Operating Income | -9,230 | -9,829 | -8,503 | -7,706 | -5,677 |
Interest Expense | 0 | 1,486 | 0 | 0 | 0 |
Other Income | 10,922 | -18 | 14,462 | 5,287 | 782 |
Pre-tax Income | 1,692 | -11,334 | 5,959 | -2,419 | -4,895 |
Net Income Continuous | 1,692 | -11,334 | 5,959 | -2,419 | -4,895 |
Minority Interests | -24 | -39 | -43 | N/A | N/A |
Net Income | $1,716 | $-11,295 | $6,002 | $-2,419 | $-4,895 |
EPS Basic Total Ops | 0.11 | -0.71 | 0.38 | -0.14 | -0.32 |
EPS Basic Continuous Ops | 0.11 | -0.71 | 0.37 | -0.15 | -0.32 |
EPS Diluted Total Ops | 0.11 | -0.71 | -0.50 | -0.14 | -0.32 |
EPS Diluted Continuous Ops | 0.11 | -0.71 | 0.36 | -0.15 | -0.32 |
EPS Diluted Before Non-Recurring Items | 0.11 | -0.71 | -0.50 | -0.15 | -0.32 |
EBITDA(a) | $-9,226 | $-9,826 | $-8,499 | $-7,702 | $-5,673 |